These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 159119)

  • 1. Neocarzinostatin: a phase I clinical trial with five-day intermittent and continuous infusions.
    McKelvey EM; Burgess MA; McCredie KB; Murphy WK; Bodey GP
    Cancer; 1979 Oct; 44(4):1182-8. PubMed ID: 159119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neocarzinostatin: report of a phase II clinical trial.
    McKelvey EM; Murphy W; Zander A; Bodey GP
    Cancer Treat Rep; 1981; 65(7-8):699-701. PubMed ID: 6454486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study with neocarzinostatin: tolerance to two hour infusion and continuous infusion.
    Ohnuma T; Nogeire C; Cuttner J; Holland JF
    Cancer; 1978 Oct; 42(4):1670-9. PubMed ID: 152143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute nonlymphocytic leukemia with neocarzinostatin.
    Griffin TW; Lister TA; Rybak ME; Rosenthal DS; Canellos GP; Woodruff R; Oliver KT
    Cancer Treat Rep; 1979; 63(11-12):1853-6. PubMed ID: 160835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I and preliminary phase II study of neocarzinostatin.
    Griffin TW; Comis RL; Lokich JJ; Blum RH; Canellos GP
    Cancer Treat Rep; 1978 Dec; 62(12):2019-25. PubMed ID: 221112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of neocarzinostatin in patients with acute leukemia.
    Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1978 Sep; 62(9):1363-5. PubMed ID: 150945
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase I study of neocarzinostatin in children with cancer.
    Rivera G; Howarth C; Aur RJ; Pratt CB
    Cancer Treat Rep; 1978 Dec; 62(12):2105-7. PubMed ID: 156067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinostatin (neocarzinostatin).
    Issell BF; Prestayko AW; Comis RL; Crooke ST
    Cancer Treat Rev; 1979 Dec; 6(4):239-49. PubMed ID: 161199
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II trial of neocarzinostatin in patients with bladder and prostatic cancer: toxicity of a five-day iv bolus schedule.
    Natale RB; Yagoda A; Watson RC; Stover DE
    Cancer; 1980 Jun; 45(11):2836-42. PubMed ID: 6445776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of neocarzinostatin (NSC 157365) in malignant hepatoma. An Eastern Cooperative Oncology Group pilot study.
    Falkson G; Von Hoff D; Klaassen D; Du Plessis H; Van Der Merwe CF; Van Der Merwe AM; Carbone PP
    Cancer Chemother Pharmacol; 1980; 4(1):33-6. PubMed ID: 6244904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of 10-deaza-aminopterin in patients with advanced cancer.
    Currie VE; Warrell RP; Arlin Z; Tan C; Sirotnak FM; Greene G; Young CW
    Cancer Treat Rep; 1983 Feb; 67(2):149-54. PubMed ID: 6825121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of homoharringtonine administered as a 5-day continuous infusion.
    Coonley CJ; Warrell RP; Young CW
    Cancer Treat Rep; 1983; 67(7-8):693-6. PubMed ID: 6871884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase I clinical study of zinostatin stimalamer (YM 881) by intravenous injection].
    Saito T; Nakao I; Wakui A; Kurihara M; Niitani H; Konno T; Tsukagoshi S; Maeda H
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1311-8. PubMed ID: 1829882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of decrease of leukemic cells and leukocytes during neocarzinostatin treatment.
    Masaoka T; Hasegawa Y; Yoshitake J; Ueda T; Takubo T
    Cancer Treat Rep; 1977; 61(1):73-5. PubMed ID: 140763
    [No Abstract]   [Full Text] [Related]  

  • 15. Neocarzinostatin in cancer chemotherapy (review).
    Maeda H
    Anticancer Res; 1981; 1(3):175-86. PubMed ID: 6211130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial of continuous infusion carboplatin and etoposide in children with refractory acute leukemia: a Pediatric Oncology Group study.
    Sadowitz PD; Dubowy R; Souid A; Pollock BH; Weinstein H; Parmley RT; Bowman WP; Land V; Vats T; Pratt C
    J Clin Oncol; 1994 Sep; 12(9):1969-73. PubMed ID: 8083718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of neocarzinostatin in digestive system cancer. 1. Administration of neocarzinostatin in advanced and recurrent carcinoma of the stomach].
    Kikuchi K; Kusama S; Furue H; Muto T; Toriyama K; Wakiya M
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1866-71. PubMed ID: 6224465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neocarzinostatin (NSC 157365) a new cancerostatic compound.
    Legha SS; Von Hoff DD; Rozencweig M; Abraham D; Slavik M; Muggia M
    Oncology; 1976; 33(5-6):265-70. PubMed ID: 141012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I-II study of piperazinedione in adults with solid tumors and acute leukemia.
    Benjamin RS; Keating MJ; Valdivieso M; McCredie KB; Livingston RA; Burgess MA; Rodriguez V; Bodey GP; Gottlieb JA
    Cancer Treat Rep; 1979 Jun; 63(6):939-43. PubMed ID: 380802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial clinical study with pyrazofurin.
    Ohnuma T; Holland JF
    Cancer Treat Rep; 1977; 61(3):389-94. PubMed ID: 872139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.